If EPS Growth Is Important To You, Zoetis (NYSE:ZTS) Presents An Opportunity
Income Investing: 6 Large-Cap Stocks With Growing Dividends
Zoetis's Q3 2024 Earnings: What to Expect
Here's How Much $1000 Invested In Zoetis 10 Years Ago Would Be Worth Today
Morgan Stanley Screens for Quality Cyclicals as Economic Surprises, Yields Back Upgrade
J.P. Morgan Maintains Zoetis(ZTS.US) With Buy Rating, Announces Target Price $230
In-Depth Examination Of 7 Analyst Recommendations For Zoetis
Zoetis Is Maintained at Overweight by JP Morgan
Zoetis Analyst Ratings
JPMorgan Adjusts Price Target on Zoetis to $230 From $225
US Pet Supplements Market Report 2024-2032, Featuring Ark Naturals, Garmon, Kemin Industries, Nestle, Purina Petcare, Novotech Nutraceuticals, Nutramax Laboratories, PetHonesty, Virbac and Zoetis - ResearchAndMarkets.com
United States Veterinary Oncology Market, Forecast & Opportunities Report to 2029, Featuring Zoetis, Virbac, Ardent Animal Health, Varian Medical Systems, PetVet Care Centers and More
Zoetis To Go Ex-Dividend On October 31st, 2024 With 0.432 USD Dividend Per Share
Zoetis Keeps Quarterly Dividend at $0.432 a Share, Payable Dec. 3 to Holders of Record Oct. 31
Press Release: Zoetis Declares Fourth Quarter 2024 Dividend
BofA Securities Maintains Zoetis(ZTS.US) With Buy Rating
Bank of America Securities Remains a Buy on Zoetis (ZTS)
Express News | Zoetis Inc : BofA Global Research Raises Price Objective to $210 From $200
TD Cowen Maintains Zoetis(ZTS.US) With Buy Rating, Maintains Target Price $214
10 Health Care Stocks Whale Activity In Today's Session